STING1 and diabetes mellitus: We believe that as systemic and detailed approaches have been recommended for monitoring cGAS–STING signaling in cultured cells and tissues of mice [193, 194], studies on the cGAS–STING pathway in diabetes and the ensuing complications are promising and feasible, and we intend to investigate the abovementioned topics to some extent in future studies.